job ratings (see below graph) for Big Pharma

02/24/24
industry:
Big Pharma
job title:
Cell Therapy
job rating:
2
It's not the job but management and leadership team's lack of integrity and open racism at senior manager & above level. Growth and development opportunities exist only for white. Promotion prospects directly correlated with incompetence!
01/31/24
industry:
Big Pharma
company:
job rating:
2
Analogy: Like in Kite Biomarin called Roche to send the cavalry to rescue the company. As in Kite it is being done by headcount reduction. Jeff A is a prominent example. Some executive and senior vice-presidents would go soon since they do not contribute but interfere by looking busy. Stock market is not impressed. Rarely companies ask the capable people who already left to return and help rebuild. Rather we may expect people streaming from Genentech and Roche following the CEO. However, they do not have right experience to match the Biomarin niche. Contraction expected, possibly 15% reduction in workforce
01/24/24
industry:
Big Pharma
company:
job rating:
1 - I hate my job
Haven for many underperformers. Their main occupation is protecting a job. National connections count in hiring and career. Still it is too big to fail organization.
01/18/24
industry:
Big Pharma
company:
job rating:
2
Bayer restructuring. Means loss of jobs. CEO could restructure himself first, if the company does not perform.
01/13/24
industry:
Big Pharma
company:
job rating:
1 - I hate my job
Company is still confused about directions to follow. Hiring is useless.
01/05/24
industry:
Big Pharma
company:
job rating:
3
Finally the white elephant may start moving
12/28/23
industry:
Big Pharma
company:
job rating:
1 - I hate my job
Roche ordered Genentech to work on application of AI in drug discovery. At Roche no one really understands it, but to their surprise Genentech is not up to the task after years of dependency on Roche.The made an agreement with Invidia who will be the real beneficiary by familiarizing itself with this domain.
12/20/23
industry:
Big Pharma
company:
job rating:
3
new ceo is interviewing existing vice-presidents to see who would stay and who has to go. This is under pretext to introduce himself and know them better. Considerations for external candidates are already in place.
12/16/23
industry:
Big Pharma
company:
job rating:
2
Wasting resources left and right
12/11/23
industry:
Big Pharma
company:
job rating:
2
Sweeping poor quality managers out the door. Still good name, so they can find positions in worse companies.

Pages

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.